Scandinavian journal of gastroenterology · 1993
Pituitary adenylate cyclase-activating peptide is a potent modulator of human colonic motility.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Schwörer H, Clemens A, Katsoulis S, Köhler H, Creutzfeldt W, Schmidt W E
Аннотация
Pituitary adenylate cyclase-activating peptide (PACAP) represents a novel brain-gut peptide with high sequence homology to vasoactive intestinal polypeptide (VIP). Since PACAP has been identified in the human gut, the effect of the two molecular forms PACAP-(1-38) and PACAP-(1-27), the hybrid PACAP-(1-23)VIP-(24-28), and VIP on the contractility of the longitudinal muscle of human sigmoid colon was tested in vitro. All peptides inhibited the spontaneous phasic contractions and relaxed concentration-dependently carbachol-precontracted preparations. The effects of the peptides remained unaffected by tetrodotoxin, by inhibition of phosphodiesterase activity, and by inhibition of nitric oxide synthesis. Apamin reduced only the effects of the PACAP peptides, whereas tetraethylammonium blocked only the effect of VIP. In conclusion, PACAP peptides and VIP mediate their relaxant effects via activation of specific PACAP and VIP receptors coupled to different potassium channels.
Предметные рубрики MeSH
4-AminopyridineApaminArginineCarbacholColon, SigmoidGastrointestinal MotilityHumansIn Vitro TechniquesMuscle ContractionMuscle RelaxationNeuropeptidesNitric OxideNitroargininePhosphodiesterase InhibitorsPituitary Adenylate Cyclase-Activating PolypeptidePotassium ChannelsTetraethylammoniumTetraethylammonium CompoundsTetrodotoxinVasoactive Intestinal Peptide